|
시장보고서
상품코드
2055070
신경 보호 시장 : 제품 유형별, 작용기전별, 용도별, 환자층별, 성별, 투여 경로별, 유통 채널별, 지역별Neuroprotection Market, By Product Type, By Mechanism of Action, By Application, By Patient Demographics, By Gender, By Route of Administration, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
신경 보호 시장은 2026년에 378억 달러로 추정되며, 2033년까지 630억 7,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 7.6%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 378억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 7.60% | 2033년 시장 규모 예측 : | 630억 7,000만 달러 |
세계 신경 보호 시장은 헬스케어 업계에서 매우 중요한 분야로 부상하고 있으며, 다양한 신경 질환 및 외상으로 인한 손상으로부터 신경계를 보호하기 위한 치료 전략의 개발과 적용에 중점을 두고 있습니다. 신경 보호에는 신경 세포 손실의 진행을 예방하거나 완화함으로써 인지 기능을 유지하고 환자의 예후를 개선하는 것을 목표로 하는 다양한 접근법이 포함됩니다. 알츠하이머병, 파킨슨병, 외상성 뇌손상, 뇌졸중 등 신경계 질환의 유병률이 증가하고 있어, 이 시장은 연구자, 제약 기업, 의료 서비스 제공업체들로부터 큰 관심을 받고 있습니다. 고령화의 진행과 이러한 질환으로 인한 부담 증가에 따라, 효과적인 신경 보호 치료법에 대한 수요가 급증하고 있으며, 이는 해당 분야의 혁신과 투자를 주도하고 있습니다.
시장 역학:
세계 신경 보호 시장의 성장은 신경 질환 유병률 증가, 고령화 심화, 신경 손상 예방을 위한 조기 개입의 중요성에 대한 인식 제고 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 알츠하이머병이나 파킨슨병과 같은 신경퇴행성 질환의 유병률은 증가 추세에 있으며, 이는 신경 보호 요법에 대한 큰 수요를 창출하고 있습니다. 또한, 사고나 스포츠 활동으로 인한 외상성 뇌손상의 발생률도 시장 성장에 기여하고 있습니다. 그러나 시장에는 의약품 개발의 높은 비용이나 혈액뇌장벽을 넘어 치료제를 전달하는 것과 관련된 과제 등 일정한 제약이 존재합니다.
게다가 신경 질환을 조기에 발견할 수 있는 효과적인 진단 도구가 부족하여, 적시의 개입과 치료를 저해하고 있습니다. 이러한 과제가 있음에도 불구하고, 이 시장에는 성장과 혁신을 위한 큰 기회가 존재합니다. 맞춤형 의료에 대한 관심이 높아지고 있으며, 표적 치료제 개발이 진전되고 있는 점은 신경 보호 분야에서 유망한 전망을 제시하고 있습니다. 유전체학, 단백질체학 및 바이오마커 발견 분야의 발전으로 인해, 새로운 약물 표적의 규명 및 정밀 치료법 개발을 위한 새로운 가능성이 열리고 있습니다. 또한, 학계, 산업계, 정부 기관 간의 협력이 강화됨에 따라 연구 개발 활동이 촉진되고, 전임상 단계의 연구 성과를 임상 적용으로 신속하게 연결하는 과정이 가속화되고 있습니다.
본 조사의 주요 특징:
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 신경 보호 시장의 주요 기업 프로파일을 작성하였습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 신경 보호 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 신경 보호 시장을 분석하는 데 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 신경 보호 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 신경 보호 시장 : 작용기전별, 2021년-2033년
제6장 세계의 신경 보호 시장 : 용도별, 2021년-2033년
제7장 세계의 신경 보호 시장 : 환자층별, 2021년-2033년
제8장 세계의 신경 보호 시장 : 성별, 2021년-2033년
제9장 세계의 신경 보호 시장 : 투여 경로별, 2021년-2033년
제10장 세계의 신경 보호 시장 : 유통 채널별, 2021년-2033년
제11장 세계의 신경 보호 시장 : 지역별, 2021년-2033년
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고 문헌 및 조사 방법
LSH 26.06.22Neuroprotection Market is estimated to be valued at USD 37.80 Bn in 2026 and is expected to reach USD 63.07 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 37.80 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.60% | 2033 Value Projection: | USD 63.07 Bn |
The global neuroprotection market has emerged as a vital sector within the healthcare industry, focusing on the development and application of therapeutic strategies to safeguard the nervous system from damage caused by various neurological disorders and injuries. Neuroprotection encompasses a wide range of approaches aimed at preventing or mitigating the progression of neuronal loss, thereby preserving cognitive function and improving patient outcomes. This market has garnered significant attention from researchers, pharmaceutical companies, and healthcare providers due to the increasing prevalence of neurological conditions such as Alzheimer's disease, Parkinson's disease, traumatic brain injury, and stroke. With the growing aging population and the rising burden of these disorders, the demand for effective neuroprotective interventions has surged, driving innovation and investment in this field.
Market Dynamics:
The global neuroprotection market growth is driven by several key factors, including the increasing prevalence of neurological disorders, growing aging population, and rising awareness about the importance of early intervention in preventing neurological damage. The prevalence of neurodegenerative diseases such as Alzheimer's and Parkinson's has been on the rise, creating a significant demand for neuroprotective therapies. Additionally, the incidence of traumatic brain injuries due to accidents and sports-related activities has also contributed to the market growth. However, the market faces certain restraints, such as the high cost of drug development and the challenges associated with delivering therapeutics across the blood-brain barrier.
Moreover, the lack of effective diagnostic tools for early detection of neurological disorders hinders timely intervention and treatment. Despite these challenges, the market presents substantial opportunities for growth and innovation. The increasing focus on personalized medicine and the development of targeted therapies offer promising avenues for neuroprotection. Advancements in genomics, proteomics, and biomarker discovery have opened up new possibilities for identifying novel drug targets and developing precision therapies. Furthermore, the growing collaboration between academia, industry, and government organizations has fostered research and development efforts, accelerating the translation of preclinical findings into clinical applications.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global neuroprotection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Biogen Inc., Amgen Inc., Novartis AG, Eli Lilly and Company, Roche Holding AG, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, AbbVie Inc., GSK (GlaxoSmithKline), Takeda Pharmaceutical Company Limited, and UCB S.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global neuroprotection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroprotection market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceuticals
- Biologics
- Nutraceuticals
- Others
- Mechanism Of Action Insights (Revenue, USD Bn, 2021 - 2033)
- Antioxidants
- Anti-inflammatory Drugs
- Neurotransmitter Modulators
- Calcium Channel Blockers
- NMDA Receptor Antagonists
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Amyotrophic Lateral Sclerosis (ALS)
- Huntington's Disease
- Traumatic Brain Injury (TBI)
- Ischemic Stroke
- Epilepsy
- Retinal Degeneration
- Glaucoma
- Spinal Cord Injuries
- Others
- Patient Demographics Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric Patients
- Adult Patients
- Geriatric Patients
- Gender Insights (Revenue, USD Bn, 2021 - 2033)
- Male
- Female
- Route Of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Injectable
- Intranasal
- Transdermal
- Sublingual
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Biogen Inc.
- Amgen Inc.
- Novartis AG
- Eli Lilly and Company
- Roche Holding AG
- Pfizer Inc.
- Sanofi S.A.
- Merck & Co., Inc.
- AstraZeneca PLC
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- AbbVie Inc.
- GSK (GlaxoSmithKline)
- Takeda Pharmaceutical Company Limited
- UCB S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Neuroprotection Market, By Product Type
- Global Neuroprotection Market, By Mechanism of Action
- Global Neuroprotection Market, By Application
- Global Neuroprotection Market, By Patient Demographics
- Global Neuroprotection Market, By Gender
- Global Neuroprotection Market, By Route of Administration
- Global Neuroprotection Market, By Distribution Channel
- Global Neuroprotection Market, By Region
3. Market Dynamics, Regulations, And Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Neuroprotection Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nutraceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Neuroprotection Market, By Mechanism of Action, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Antioxidants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurotransmitter Modulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Calcium Channel Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- NMDA Receptor Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Neuroprotection Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Alzheimer's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Parkinson's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Multiple Sclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Amyotrophic Lateral Sclerosis (ALS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Huntington's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Traumatic Brain Injury (TBI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ischemic Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retinal Degeneration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Spinal Cord Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Neuroprotection Market, By Patient Demographics, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Neuroprotection Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Neuroprotection Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Neuroprotection Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Neuroprotection Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Biogen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GSK (GlaxoSmithKline)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- UCB S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
